Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical Trials.

Area of Science:

• Oncology
• Neuro-oncology
• Clinical Trial Design

Background:

• Drug development for rare and difficult-to-treat solid tumors, such as glioblastoma, faces significant timeline challenges.
• Leveraging external patient-level data can enhance the efficiency and precision of clinical trial design and analysis.
• Access to high-quality, external patient-level data is a major hurdle for academic research groups.

Purpose of the Study:

• To introduce the Glioblastoma External (GBM-X) Data Platform, a resource designed to facilitate the use of external data in neuro-oncology research.
• To enable investigators to access and analyze existing data collections for improved clinical trial planning and execution.
• To accelerate the evaluation of novel therapies for glioblastoma and other rare tumors.

Main Methods:

• Development of the Glioblastoma External (GBM-X) Data Platform.
• Facilitation of data collection, integration, and analysis for neuro-oncology research.
• Establishment of a collaborative framework for ongoing data growth and updates.

Main Results:

• The GBM-X platform provides an accessible process for utilizing external data.
• It enables contextualization of single-arm trials and improves inference on treatment effects.
• The platform is designed to foster collaboration and continuous data expansion.

Conclusions:

• The GBM-X Data Platform offers a valuable resource to accelerate drug discovery for rare and challenging tumors.
• It serves as a model for leveraging external data to improve the efficiency of oncology clinical trials.
• Collaboration and data sharing are crucial for advancing therapeutic development in neuro-oncology.